Our findings established for the first time that ebv-miR-BART7 suppressed the expression of GFPT1 and TGFβ1 that could reduce the sensitivity of NPC cells to radiation treatment. The gene discussed is TGFB1; the disease is nasopharyngeal carcinoma.